Comvita Limited/Announcement
Comvita Limited logo

Turnaround on track at Comvita

Earnings Results24 February 2021CVTIndustrials

25 February 2021

Turnaround on track at Comvita


Headlines

▪ Reported NPAT $3.5M vs. ($13M) in PCP

▪ Reported EBITDA* $10.6M vs. ($8.8M) in PCP, an improvement of $19.4M

▪ Reported revenue $98.9M, +5.5% vs. PCP

▪ Double-digit top and bottom-line growth in focus growth markets

▪ Net debt reduction** $1.6M, Inventory reduction** $14M, Operating cash inflow $9.4M

▪ Gross Profit +1080 bps, +28.3% vs. PCP

▪ Marketing Investment +$2.1M or +25%

▪ $15M business transformation plan on track:

• Additional $10M transformation phase two launched

▪ 37% reduction in total recordable injury frequency rate (TRIFR)

▪ Full year guidance maintained; dividends expected to resume at full year


Financial results for the six months ended

$M

31 December

2020

Unaudited

31 December

2019

Unaudited

Revenue 98.9 93.9

Gross Profit 48.5 35.8

EBITDA* 10.6 (8.8)

Net Profit/(Loss) after tax 3.5 (13.0)

Net debt 13.9 93.2

Inventory 98.5 116.1

*EBITDA: Earnings before interest, tax, depreciation, and amortisation

** Performance vs. 30 June 2020


Comvita (NZX:CVT) today announced that for the six-month period ending 31 December 2020, it returned

to profitability with net profit after tax (NPAT) reported as $3.5M versus a $12.97M loss in the prior

corresponding period (PCP).


Reported EBITDA was $10.6M versus a loss of $8.8M in the PCP. Revenue increased to $98.9M, +$5.5%

versus PCP, or 6.7% in constant currency, with strong growth seen in focus growth markets and its core

Mānuka category. Marketing investment designed to support Comvita’s long-term growth ambition

increased by 25% on the PCP as Comvita activated plans to drive brand affinity and tell its founding story

to discerning consumers around the world.


Commenting on the performance, Comvita Chairman, Brett Hewlett, said “We’re pleased with the progress

the team has delivered over the last year. The Board and management have continued to transform the

business at pace looking to ensure we deliver the performance that all Comvita stakeholders should

expect. The result shared today shows that the ongoing transformation is multi-dimensional with revenue,

margin, and earnings improvements, along with good financial and capital disciplines evidenced in net

debt reduction, inventory reduction and cash generation. In line with our previous disclosure, and subject


Page 2 of 4

to delivering full year guidance, the Board reconfirms its commitment to resume dividend payments at the

end of this financial year.”


Group CEO, David Banfield, says “The team and I are encouraged by the results that we share today. We

remain totally focused on delivering our new long-term sustainable business model that will enable us to

simplify and streamline the business further, invest in telling our unique brand story to discerning

consumers around the world, and connect with our fantastic in-market teams to deliver the most

compelling consumer proposition in market. We look forward to sharing further progress over the course

of the second half of the year.”


Focus growth markets performing strongly

Comvita’s focus growth markets, China and North America, showed strong performance in this period with

both markets delivering double-digit top and bottom-line growth.


China is the world’s biggest honey market valued at $1.8Bn, Comvita’s long-term goal is to target market

growth (growing the total addressable market) and market share growth. Revenue in China grew by 20%

and net contribution by 28% versus the PCP, as Comvita invested in long-term brand building activity.

Comvita also significantly strengthened leadership capability at its in-China subsidiary funded by

efficiencies across the Group with a focus on delivering strong foundations for long-term profitable growth.


Comvita North America posted another strong result with revenue increased by 38% and net contribution

by 222% (though there was a delay in timing of some marketing activities to H2). Retail distribution

increased by 170% over the PCP, which is hugely encouraging, and digital sales increased by 87%, now

representing 41% of H1 sales. Comvita is the fastest growing Mānuka honey brand in North America.


Unique business model shows encouraging signs

Comvita has a unique ‘End to End’ business model with around 350 people employed in markets outside

of New Zealand to ensure that Comvita is better connected to customers and consumers in market, and is

able to adapt at speed to meet local market changes and needs. A particular strength of this model has

been evidenced in Mainland China and Asia where Comvita has been able to offset the impact of the

challenges in the Daigou market in Australia and New Zealand. This model also enables the business to

continue to perform strongly even with travel and tourism being so restricted.


Headwinds in Australia and New Zealand

The business in Australia and New Zealand has traditionally been focused on tourism, travel, Daigou,

cross-border, and retail serving Asian consumers. This has meant a narrow distribution focus and lack of

digital activity and has limited reach outside this core consumer group. This has resulted in a lack of

distribution and brand awareness of our compelling story across the broader target demographic in

Australia and New Zealand and has meant that COVID disruptions have had a material impact on revenue

and earnings (particularly in Australia).


Revenue in Australia fell by $5.5M versus the PCP due to the challenges in these channels. As previously

advised Comvita sees success in its home markets as a prerequisite for long-term success. Comvita has

launched a review of the optimum structure for its Asian health Daigou business to ensure consumer

communication, experience and brand proposition is enhanced.


The new Immersive Comvita Wellness Lab experience in Auckland will open in March 2021 as Comvita

shares its amazing founding story and the story of the hive with New Zealand consumers.



Page 3 of 4

$15M Transformation on track

Comvita has made good progress on its $15M business transformation programme announced last year,

with the benefits being reflected in these Interim results. Overall Comvita has delivered a strong

improvement in gross profit of 1080 bps or +28.3% vs. PCP, radically flattened the organisation structure

and simplified the business significantly (legal entities and JV’s). Its previously reported goal to reduce the

total SKU count by 30% is on track to be delivered, freeing up cash and bringing more focus in the process.

It is also on track to deliver underlying cost reductions of $5M.


New additional $10M transformation phase two announced

Comvita aims to be the highest quality, lowest cost producer of Mānuka honey while also having a

relentless focus on flattening the organisational structure and putting the consumer, and consumer

experience, at the heart of their thinking. In order to ensure that the business model enables it to invest in

telling its long-term story, to connect with consumers and deliver returns to shareholders in-line with

expectation, Comvita has today launched an additional three-year $10M transformation phase two. This

programme is designed to deliver an additional 400-450 bps improvement in margin by June 2024 and

enable it to accelerate brand investment and deliver on its mid-single digit revenue growth expectations.

Comvita will invest an additional $1.5M p.a. to deliver this phase two transformation.


Good progress on digital transformation

Comvita has set out its aim to grow digital sales to 50% of total group sales by 2025. Good progress has

been made with total digital sales accounting for 32% of Group sales in this period. Comvita under index

digital sales in all markets that have been slow to embrace the digital channel opportunity (NZ, AU, UK and

HK). It is notable that all these markets share the same narrow distribution model and have

underperformed during this period. Action is already underway to address this with the recent

announcement of the partnership with The Hut Group.


Net debt, inventory, and cash improvements

Comvita continued its strategy to streamline the business and deliver on its low debt, lower Inventory, and

cash generative plan. During this period net debt decreased by $1.6M, inventory by $14M, and $9.4M in

operating cash was generated.


Full year guidance maintained

Comvita maintained full year guidance of an EBITDA range of NZD $20-$23M in the period ending

30 June 2021. Comvita also reaffirmed its intention to resume dividend payments following delivery of its

full year guidance.


Looking forward - Building a better business

Good progress has been made on stabilising and transforming the business in line with Comvita’s three-

part plan to:

1: Stabilise performance

2: Transform the organisation

3: Build long term resilience and growth


Comvita is focused on putting in place long-term scalable foundations and processes that enable the

business to excel in coming years. “We’re pleased with progress so far but equally recognise the additional

work ahead as we ‘Stride” into this next phase.“ added Banfield.


Comvita remains committed to delivering mid-single-digit revenue growth in constant currency, a 20%

EBITDA margin by 2025, and a double-digit five-year EPS CAGR. In addition, Comvita reiterated its aim to be

carbon neutral by 2025 and carbon positive by 2030.


Page 4 of 4

Banfield, concludes “This is a special chapter in Comvita’s rich history as we turn 50 years of age in 2024/5.

The team and I are totally committed to delivering long-term profitable growth and ensuring that we put in

place the foundations at Comvita to thrive for another 50 years. We continue our transformation of Comvita

and remain committed to pay back the support shown by the Board, the extended Comvita whānau and all

our stakeholders.”


David Banfield Brett Hewlett

CEO Chair


ENDS.



For further information contact:

Kelly Bennett, One Plus One Communications

Mobile: +64 21 380 035

Email: kelly.bennett@oneplusonegroup.co.nz




Background information

About Comvita (www.comvita.co.nz) Comvita (NZX:CVT) was founded in 1974 and is the pioneer and global

market leader of the Mānuka honey category. Comvita is committed to the long-term development of

Mānuka and Bee products backed by unrivalled scientific knowhow. Comvita recently announced its

sponsorship of the NZ pavilion at the World Expo in Dubai focusing on Kaitiakitanga (guardianship and

protection of the planet).

---

Template
Results announcement

(for Equity Security issuer/Equity and Debt Security issuer)

Updated as at 17 October 2019



Results for announcement to the market

Name of issuer Comvita Limited

Reporting Period 6 months to 31 December 2020

Previous Reporting Period 6 months to 31 December 2019

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$98,885 5.4%

Total Revenue $98,885 5.4%

Net profit/(loss) from

continuing operations

$3,455

Total net profit/(loss) $3,455

Interim/Final Dividend

Amount per Quoted Equity

Security

The Board of Directors do not propose to pay an interim

dividend

Imputed amount per Quoted

Equity Security

Not Applicable

Record Date Not Applicable

Dividend Payment Date Not Applicable

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

$2.43 $2.36

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Please refer to profit announcement and attachments for

commentary.

Authority for this announcement

Name of person


authorised

to make this announcement

David Banfield, CEO

Contact person for this

announcement

Kelly Bennett

Contact phone number +64 21 380 035

Contact email address kelly.bennett@oneplusonegroup.co.nz

Date of release through MAP


25 February 2021


Unaudited interim financial statements and the investor presentation accompany this

announcement.

---

Comvita Condensed Interim Financial Statements 2020 - PI
FOR THE SIX MONTHS ENDED 31 DECEMBER 2020

COMVITA LIMITED

FINANCIAL

STATEMENTS

CONDENSED INTERIM

Comvita Condensed Interim Financial Statements 2021 - P1
Directors’ declaration

Condensed interim income statement

Condensed interim statement of comprehensive income

Condensed interim statement of changes in equity

Condensed interim statement of financial position

Condensed interim statement of cash flows

Notes to the interim financial statements

Company Directory

2

3

4

5

6

7

8 - 17

18 - 19

CONTENTS

Comvita Condensed Interim Financial Statements 2021 - P2Comvita Condensed Interim Financial Statements 2021 - P3
Condensed Interim Income Statement

In the opinion of the directors of Comvita Limited, the interim financial statements and the notes, on

pages 3 to 17:

• comply with New Zealand generally accepted accounting practice and fairly state the financial

position of the Group as at 31 December 2020 and the results of their operations and cash flows for

the period ended on that date

• have been prepared using appropriate accounting policies, which unless otherwise stated have been

consistently applied and supported by reasonable judgements and estimates

The Directors believe that proper accounting records have been kept which enable, with reasonable

accuracy, the determination of the financial position of the Group and facilitate compliance of the

financial statements with the Financial Reporting Act 2013 and the Financial Markets Conduct Act 2013.

The Directors consider that they have taken adequate steps to safeguard the assets of the Group, and

to prevent and detect fraud and other irregularities. Internal control procedures are also considered

to be sufficient to provide reasonable assurance as to the integrity and reliability of the financial

statements.

The Directors are pleased to present the financial statements of Comvita Limited for the period ended

31 December 2020.

For and on behalf of the Board of Directors:

Directors’ Declaration


Brett Hewlett Luke Bunt

24 February 2021 24 February 2021

For the 6 months ended

In thousands of New Zealand dollars

Note

31 December 2020

Unaudited

31 December 2019

Unaudited

Revenue98,88593,854

Cost of sales(50,385)(58,041)

Gross profit48,50035,813

Other income2,001584

Marketing expenses(10,979)(8,808)

Selling and distribution expenses(22,252)(25,307)

Research and development expenses(1,210)(746)

Administrative expenses(10,903)(12,041)

Operating profit/(loss) before financing costs5,157(10,505)

Finance income5516164

Finance expenses5(1,250)(3,497)

Net finance costs(734)(3,333)

Share of profit of equity accounted investees8(8)11

Impairment of equity accounted investees-(2,310)

Profit/(loss) before income tax4,415(16,137)

Income tax(960)3,167

Profit/(loss) for the period3,455(12,970)

Earnings per share:

Basic earnings per share (NZ cents)64.95(26.17)

Diluted earnings per share (NZ cents)64.95(26.17)

The notes on pages 8 to 17 are an integral part of these condensed interim financial statements.

*EBITDA is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the

performance of the core operations of our business. A reconciliation of EBITDA to Profit before tax is provided in Note 16.

Supplementary non-GAAP information – EBITDA*1610,595 (8,829)

Comvita Condensed Interim Financial Statements 2021 - P4Comvita Condensed Interim Financial Statements 2021 - P5
For the 6 months ended

In thousands of New Zealand dollars

31 December 2020


Unaudited

31 December 2019

Unaudited

Profit/(loss) for the period3,455(12,970)

Items that are or may be reclassified subsequently to the income statement

Foreign currency translation differences for foreign operations(2,058)(505)

Foreign currency translation differences for equity accounted investees-(540)

Fair value movement – available for sale reserve396-

Effective portion of changes in fair value of cash flow hedges1,2081,137

Income tax on these items(262)(221)

Income and expense recognised directly in other comprehensive income(716)(129)

Total comprehensive income for the period 2,739(13,099)

Condensed Interim Statement of

COMPREHENSI V E INCOME

For the 6 months ended 31 December 2019

In thousands of New Zealand dollars

Share

capital

Foreign

currency

translation

reserve

Hedging

reserve

Fair value

reserve

Retained

earnings Total

Balance at 1 July 2019151,245(4,467)(1,723)-28,300173,355

Total comprehensive income for the period

(Loss) after tax for the period----(12,970)(12,970)

Other comprehensive income (net of tax):

Foreign currency translation differences for equity

accounted investees

-(540)---(540)

Foreign currency translation differences for foreign

operations

-(408)---(408)

Effective portion of changes in fair value of cash flow

hedges

--819--819

Total other comprehensive income for the period-(948)819-(12,970)(13,099)

Total comprehensive income for the period-(948)819-(12,970)(13,099)

Transactions with owners, recorded directly in equity

Share based payment----239239

Issue of ordinary shares

- executive share scheme(7)----(7)

- staff share scheme(5)----(5)

Purchase of treasury stock(318)----(318)

Supplier share scheme502---(43)459

Total transactions with owners172---196368

Balance at 31 December 2019151,417(5,415)(904)-15,526160,624

Balance at 1 July 2020200,104(3,809)(527)(2,640)18,620211,748

Total comprehensive income for the period

Loss after tax for the period----3,4553,455

Other comprehensive income (net of tax)

Fair value movement in equity instruments---396-396

Disposal of equity instruments---2,244(2,244)-

Foreign currency translation differences for foreign

operations

-(1,982)---(1,982)

Effective portion of changes in fair value of cash flow

hedges

--870--870

Total other comprehensive income for the period-(1,982)8702,640(2,244)(716)

Total comprehensive income for the period-(1,982)8702,6401,2112,739

Transactions with owners, recorded directly in equity

Share based payments----117117

Issue of ordinary shares:

- executive share scheme(6)----(6)

- staff share scheme(14)----(14)

Supplier share scheme407----407

Total transactions with owners387---117504

Balance at 31 December 2020200,491(5,791)343-19,948214,991

Condensed Interim Statement of

CHANGES IN EQUITY

The notes on pages 8 to 17 are an integral part of these condensed interim financial statements.The notes on pages 8 to 17 are an integral part of these condensed interim financial statements.

Comvita Condensed Interim Financial Statements 2021 - P6Comvita Condensed Interim Financial Statements 2021 - P7
As at

In thousands of New Zealand dollars

December 2020December 2019June 2020

NoteUnauditedUnauditedAudited

Assets

Property, plant and equipment60,26258,34556,829

Biological assets3,7944,0983,795

Intangible assets and goodwill38,79140,28039,467

Investments in equity accounted investees

8

6,2538,9166,261

Right of use assets12,99211,49811,447

Other investments82,6488

Deferred tax asset8,4409,6428,043

Total non-current assets130,540135,427125,850

Inventory

10

98,549116,139112,679

Trade receivables26,22328,91317,726

Sundry receivables

7

12,12212,74612,349

Cash and cash equivalents

11

14,39710,19916,680

Derivatives

9

38938-

Tax receivable528508366

Assets held for sale--773

Total current assets152,208168,543160,573

Total assets282,748303,970286,423

Liabilities

Loans and borrowings

11

28,300103,35032,200

Lease liabilities9,9898,8817,891

Deferred tax liability2,0032,3462,194

Employee benefits329405414

Total non-current liabilities40,621114,98242,699

Trade and other payables17,51020,43122,707

Lease liability3,4512,7653,744

Employee benefits3,5742,9413,653

Tax payable2,6011,0551,158

Derivatives

9

-1,172714

Total current liabilities27,13628,36431,976

Total liabilities67,757143,34674,675

Equity

Issued capital200,491151,417200,104

Retained earnings19,94815,52618,620

Reserves

(5,448)

(6,319)(6,976)

Total equity214,991160,624211,748

Total equity and liabilities282,748303,970286,423

For the 6 months ended

In thousands of New Zealand dollars

31 December 202031 December 2019

NoteUnauditedUnaudited

Receipts from customers89,91093,631

Payments to suppliers and employees(78,707)(89,810)

Interest received1113

Interest paid(1,250)(2,374)

Taxation paid(535)(573)

Net cash flows from operating activities129,429887

Interest from related parties1828

Proceeds from disposal of investment396-

Payment for loans & prepayment to equity accounted investee(1,493)(1,304)

Payment for the acquisition of property, plant and equipment(5,394)(1,731)

Receipt from disposal of property, plant and equipment997255

Payment for the acquisition of intangibles(184)(278)

Net cash flows from investing activities(5,660)(3,030)

Payment for redemption of employee shares(20)(12)

Payment for purchase of treasury stock-(318)

Repayment of lease liabilities(1,623)(1,527)

(Repayment) / drawdown of loans and borrowings(3,900)4,100

Net cash flows from financing activities(5,543)2,243

Net increase in cash and cash equivalents(1,774)100

Cash and cash equivalents at the beginning of the period16,68010,314

Effect of exchange rate fluctuations on cash held(509)(215)

Cash and cash equivalents at the end of the period14,39710,199

Represented as:

Cash and cash equivalents1114,39710,199

Total14,39710,199


Condensed Interim Statement of

FINANCIAL POSITION

Condensed Interim Statement of

CASH FLOWS

The notes on pages 8 to 17 are an integral part of these condensed interim financial statements.The notes on pages 8 to 17 are an integral part of these condensed interim financial statements.

Comvita Condensed Interim Financial Statements 2021 - P8Comvita Condensed Interim Financial Statements 2021 - P9
1. REPORTING ENTITY

Comvita Limited (the “Company”) is a company domiciled in New

Zealand and registered under the Companies Act 1993 and listed

on the New Zealand Stock Exchange (“NZX”). The Company is an

issuer in terms of the Financial Reporting Act 2013 and Financial

Markets Conduct Act 2013.

The condensed interim financial statements of the Group for

the six months ended 31 December 2020 comprise the Company

and its subsidiaries (together referred to as the “Group”) and the

Group’s interest in equity accounted investees.

The principal activity of the Group is that of manufacturing and

marketing quality natural health products, apiary ownership and

management.

2. BASIS OF PREPARATION

(a) Statement of compliance

The Company is a FMC reporting entity for the purposes of the

Financial Reporting Act 2013 and under Part 7 of the Financial

Markets Conduct Act 2013. These Financial Statements comply

with these Acts and have been prepared in accordance with the

New Zealand Equivalents to International Financial Reporting

Standards as appropriate for profit-oriented entities.

The condensed interim financial statements do not include all of

the information required for full annual financial statements and

should be read in conjunction with the group financial statements

as at and for the year ended 30 June 2020.

The condensed interim financial statements were approved by the

Board of Directors on 24 February 2021.

(b) Basis of measurement

The financial statements have been prepared on the historical

cost basis except for derivative financial instruments, financial

instruments designated as fair value through other comprehensive

income, biological assets and leases which are measured at fair

value. Fair values have been determined for measurement and/

or disclosure purposes on the same basis as those applied by the

Group in the financial statements as at and for the year ended 30

June 2020.

(c) Functional and presentation currency

These financial statements are presented in New Zealand dollars

($), which is the Company’s functional currency. Amounts have

been rounded to the nearest thousand.

(d) Use of estimates and judgements

The preparation of condensed interim financial statements in

accordance with NZ IAS 34 Interim Financial Reporting requires

management to make judgements, estimates and assumptions

that affect the application of accounting policies and the reported

amounts of assets, liabilities, income and expenses. Actual results

may differ from these estimates.

In preparing these condensed interim financial statements, the

significant judgements made by management in applying the

Groups accounting policies and the key sources of estimation

uncertainty were the same as those applied to the financial

statements as at and for the year ended 30 June 2020.

2. BASIS OF PREPARATION

(CONTINUED)

(e) Covid-19 considerations

Covid-19 considerations Comvita is classified as an ‘Essential’

business by the New Zealand Government, therefore having no

impact on the manufacturing process of the Group. For the period

ended 31 December 2020 the Group has not been significantly

impacted by COVID-19. There has been a strong demand in sales,

in particular in online channels across all markets. An assessment

over the carrying value of assets and liabilities has been performed

and the Group has recognised provisions where necessary relating

to the impact of COVID-19. The Group continues to operate as a

going concern and Senior Management continue to closely monitor

the situation.

(f) Reclassification of freight expenses

From 1 July 2020, the business has changed the classification

of freight expenses from distribution expenses to cost of goods

sold. For consistency, $3,014,000 of freight expenses have been

reclassified from operating expenses to cost of goods sold for the

six months ended 31 December 2019.

3. SIGNIFICANT ACCOUNTING

POLICIES

The accounting policies applied in these condensed interim financial

statements are the same as those applied in the Group’s financial

statements as at and for the year ended 30 June 2020.

4. SEGMENT REPORTING

A review of operating segments has been completed in the current

year and this has resulted in a change to reported segments.

Previously reported segment information has been restated in line

with the operating segments described below.

Segment information is presented in the condensed interim

financial statements in respect of the Group’s contribution

segments which are the primary basis of decision making. The

contribution segment reporting format reflects the Group’s

management and internal reporting structure.

Performance is measured based on contribution which is a

measure of profitability that the segment contributes to

the Group. Contribution is used to measure performance as

management believes that such information is most relevant in

evaluating the results of certain segments. Inter-segment pricing is

determined on an arms-length basis.

Each segment sells Comvita’s range of products. Comvita’s range

of products primarily include products with apiary and other

natural ingredients.

The Company is organised primarily by geographic location of its

subsidiaries.

4. SEGMENT REPORTING (CONTINUED)

The Group has five reportable segments as described below:

Greater ChinaThis segment reports both revenue and related costs for the China and Hong Kong markets.

ANZAustralia and New Zealand (ANZ) segment captures both revenue and related costs for the ANZ market.

Rest of AsiaThis segment captures both revenue and related costs of all of our Asian operations and customers excluding Greater

China.

North AmericaThis segment reports both revenue and related costs for sales to customers in North America.

EMEAThe Europe, Middle East and Africa (EMEA) segment captures both revenue and related costs for the EMEA markets.

For the 6 months to 31 December 2020 and 31 December 2019 unaudited

In thousands of New Zealand dollars

Contribution

segments

Greater

ChinaANZRest of AsiaNorth AmericaEMEA

Total

reportable

segments

Other

segmentsTotal

For the six months

to 31 December2020201920202019202020192020201920202019202020192020201920202019

Contribution

Segments

Revenue47,61543,84218,09222,72612,5728,49611,6178,4143,3943,44493,29086,9225,5957,00698,88593,928

Contribution11,2327,8845,7696,0713,7471,4943,031941139(926)23,91815,4644181,11224,33616,576

Non attributable (other corporate expenses)(21,180)(27,845)

Financial income and expenses (Note 5)(734)(3,333)

Other income2,001584

Share of profit of equity accounted investees (Note 8)(8)11

Impairment of equity accounted investees- (2,130)

Net profit/(loss) before tax4,415(16,137)

Total assets

In thousands of New Zealand dollars

December 2020

Unaudited

December 2019

Unaudited

June 2020

Audited

Total assets for reportable segments143,054124,834128,266

Other investments82,6488

Investment in equity accounted investees6,2538,9166,261

Other unallocated assets 133,433167,572151,888

Consolidated total assets282,748303,970286,423

Notes to the Condensed Interim Financial StatementsNotes to the Condensed Interim Financial Statements

Comvita Condensed Interim Financial Statements 2021 - P10Comvita Condensed Interim Financial Statements 2021 - P11
5. FINANCIAL INCOME AND EXPENSES

In thousands of New Zealand dollars

Note

31 December 2020

Unaudited

31 December 2019

Unaudited

Interest income110156

Dividend income98

Net foreign exchange gain397-

Finance income516164

Interest expense on financial liabilities measured at amortised cost(1,048)(2,174)

Interest expense on lease liabilities(202)(200)

Net foreign exchange loss-(969)

Net loss in fair value of derivatives designated at fair value through the income

statement:

- SeaDragon options9-(154)

Finance expense(1,250)(3,497)

6. EARNINGS PER SHARE

Basic earnings per share - weighted average number of ordinary shares

In thousands of shares

31 December 2020

Unaudited

31 December 2019

Unaudited

Issued ordinary shares at beginning of year 69,78049,555

Effect of shares issued during the period11(3)

Weighted average number of ordinary shares at the end of the period69,79149,552

Earnings3,45512,970

Basic earnings per share (NZ cents)4.95(26.17)

Diluted earnings per share – weighted average number of ordinary shares

In thousands of shares

31 December 202031 December 2019

Weighted average number of ordinary shares (basic)69,79149,552

Effect of stock entitlements issued-582

Weighted average number of diluted shares at the end of the period69,791 50,134

Diluted earnings per share (NZ cents)4.95(26.17)

The effect of stock entitlements is nil where the exercise price is higher than the average share price for the year, in accordance with

NZ IAS 33 Earnings per share. When there is a net loss the diluted earnings per share cannot be less than the basic earnings per share.

7. SUNDRY RECEIVABLES

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Prepayments5,9464,3855,307

Loans to equity accounted investees (note 8c)4,8355,6614,819

Loan receivable – related parties (note 8d)5671,224567

Management personnel (note 13)450-450

Other receivables 3241,4761,206

Total sundry receivables12,12212,74612,349

8. INVESTMENTS IN EQUITY ACCOUNTED INVESTEES

(a) Investments in Equity Accounted Investees Comprises:

Country of

Incorporation

Ownership

Interest Held

Balance

Date

Principal Activity

Makino Station LimitedNew Zealand50%30 JuneApiary and land ownership

Gan Supply JV Limited New Zealand33%30 JuneApiary

Putake Group Holdings Limited

*

New Zealand50%30 June Apiary

Manuka Research Partnership LimitedNew Zealand31.77%30 June Shareholding ceased on 24 August 2020

Medibee Pty Limited

**

Australia50%30 June Apiary

Apiter S.A. Uruguay20%31 JulyManufacturing, selling and distribution

Kaimanawa Honey Limited PartnershipNew Zealand50%30 JuneCeased operating 10 November 2019

*On 30 November 2020, Comvita signed a Deed of Postponement in favour of ANZ in relation to Comvita’s lending to Putake Group Holdings Limited and

Putake Group Limited.

** Medibee Apiaries has a funding arrangement with HSBC and Comvita has signed a several guarantee for its share of the facility, which is AUD $5,500,000.


(b) Carrying value of Investments in Equity Accounted Investees

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Opening balance – 1 July6,2619,7559,755

Impairment

--(2,543)

Share of profit

(8)11(174)

Transfer share of loss to receivable

-(310)(310)

Foreign exchange movements recognised in other

comprehensive income

-(540)(467)

Closing Balance

6,2538,9166,261

(c) Loans to equity accounted investees

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Loan receivable

Makino

4,0893,9114,007

Putake

-925-

Apiter

534573600

Gan Supply JV

212252212

Total

4,8355,6614,819

Interest receivable

Makino

754577673

Apiter

311423

Total

785591696

Interest income from Makino was $81,000 for the six months ended 31 December 2020 (31 December 2019: $96,000).

Interest income from Apiter was $8,000 for the six months ended 31 December 2020 (31 December 2019: $9,000).

Notes to the Condensed Interim Financial StatementsNotes to the Condensed Interim Financial Statements

Comvita Condensed Interim Financial Statements 2021 - P12Comvita Condensed Interim Financial Statements 2021 - P13
8. INVESTMENTS IN EQUITY ACCOUNTED INVESTEES (CONTINUED)

(d) Loans to related parties

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Nga Pi Honey Ltd (Gan Supply JV)

567567567

Casa Base Trustees (Putake)

-657-

Total

5671,224567

Loans to Nga Pi Honey Limited and Casa Base Trustees are secured over their investment in the equity accounted investee.

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Interest receivable

Nga Pi Honey Ltd (Gan Supply JV)

---

Casa Base Trustees (Putake)

-92-

Total

-92-

The Group’s interest income on the loan to Nga Pi Honey Ltd was $18,000 for the six months ended 31 December 2020 (31 December

2019: $18,000). Interest income on the loan to Casa Base Trustees was nil for the six months ended 31 December 2020 (31 December 2019:

$18,000).

(e) Transactions with equity accounted investees

In thousands of New Zealand dollars

Sale of goods and services

Purchases of goods and services

Transaction value

Balance due fromTransaction valueBalance owing to

31 December 2020

Kaimanawa-

---

Makino 58

-402-

Gan Supply JV8

-478-

Putake-

-9-

Apiter -

-1,509-

31 December 2019

Kaimanawa609

-537*-

Makino 210

---

Gan Supply JV6

3348-

Putake46

17336

Apiter -

-2,174-

* This number includes hives and equipment totalling $518,000 purchased by Kiwibee Medical Limited related to the wind-up of the

Joint Venture.

9. DERIVATIVES

The table below analyses financial instruments carried at fair value, by valuation method. These are all level 2 on the fair value hierarchy,

as they include inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e., as

prices) or indirectly (i.e., derived from prices). There have been no transfers between levels in either direction during the period.

In thousands of New Zealand dollars

31 December

2020

Unaudited

31 December

2019

Unaudited

30 June

2020

Audited

Derivatives – assets (hedging instrument)

389

Derivatives – SeaDragon options

-38-

Total assets

38938-

Derivatives – liabilities (hedging instrument)

-(1,172)(714)

Total liabilities

-(1,172)(714)

Derivative – assets and liabilities (hedged) and designated at fair value through the income statement.

The Group’s Level 2 fair values for simple over-the-counter derivative financial instruments are based on broker quotes. Those quotes

are tested for reasonableness by discounting expected future cash flows using market interest rate for a similar instrument at the

measurement date. Fair values reflect the credit risk of the instrument and include adjustments to take account of the credit risk of the

Group entity and counterparty when appropriate.

The Group determines Level 2 fair value through the application of the Binomial Model (2019: Binomial Model). Inputs include, the share

price (a Level 1 input), risk free rate of the remaining life of the warrant, and the volatility of the share price.

Fair values

The fair value of all financial assets and liabilities is the same as the carrying amount.

10. INVENTORY

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Raw materials65,73381,70477,334

Work in progress314706842

Finished goods32,50233,72934,503

Total inventory98,549116,139112,679

Inventory written off during the period ended 31 December 2020 has been recognised within cost of goods sold - $288,000 (2019:

$494,000).

Notes to the Condensed Interim Financial StatementsNotes to the Condensed Interim Financial Statements

Comvita Condensed Interim Financial Statements 2021 - P14Comvita Condensed Interim Financial Statements 2021 - P15
11. LOANS AND BORROWINGS

This note provides information about the contractual terms of the Group’s interest-bearing loans and borrowings issued and repaid during

the periods presented.

Terms and debt repayment schedule

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

30 June 2020

Audited

Balance at beginning of period32,20099,25099,250

(Repayment)/drawdown of long term borrowings - net(3,900)4,100(67,050)

Balance at end of period28,300103,35032,200

Represented as:

Current loans and borrowings---

Non-current loans and borrowings28,300103,35033,200

Total loans and borrowings28,300103,35033,200

Less: cash and cash equivalents(14,397)(10,199)(16,680)

Total net debt13,90393,15115,520

The Group was in compliance with banking covenants during the period and as at 31 December 2020.

The Group’s loans and borrowings has an expiry date of 1 July 2022.

12. RECONCILIATION OF THE PROFIT/(LOSS) FOR THE PERIOD WITH THE NET

CASH FROM OPERATING ACTIVITIES

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

Profit/(loss) for the period3,455(12,970)

Items not involving cash flows:

Depreciation4,0453,941

Amortisation8411,149

Gain on disposal of non-current assets (237)(95)

Share based payments117240

Wind-up of equity accounted investees -1,070

Impairment of equity accounted investees-2,310

Supplier share scheme – inventory purchase407459

Loss on fair value of biological assets-72

Loss on fair value of SeaDragon derivatives -154

Share of profit in equity accounted investees8(11)

Profit/(loss) adjusted for non-cash items8,636(3,681)

Movement in working capital items:

Change in inventories14,13016,053

Change in trade receivables(8,497)1,965

Change in sundry debtors and prepayments290103

Change in trade and other payables(5,622)(10,536)

Change in tax payable1,281361

Change in deferred tax(588)(3,860)

Movement in working capital items from foreign currency translation reserve(1,353)(363)

Other movements:

Movement of deferred tax in equity(414)(222)

Prepayment to equity accounted investee1,5091,257

Interest income from investing activities(99)(143)

Foreign currency reserve156(47)

Net cash from operating activities9,429887

13. RELATED PARTIES

Transactions with key management personnel

Key management compensation comprised:

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

Short term employee benefits1,910940

Share based payments 4690

Total1,9561,030

Notes to the Condensed Interim Financial StatementsNotes to the Condensed Interim Financial Statements

Comvita Condensed Interim Financial Statements 2021 - P16Comvita Condensed Interim Financial Statements 2021 - P17
13. RELATED PARTIES( CONTINUED)

Other transactions with key management personnel

On the 13 March 2020, the Company issued 307,488 ordinary shares from treasury stock to CEO David Banfield. The subscription price

for the shares was satisfied partly through the provision of a $450,000 interest free loan, with the remainder settled by David Banfield in

cash. The acquisition of shares by David Banfield was at market value, calculated as the volume weighted average of prices at which CVT

shares traded over the prior 10 trading days.

Directors and other key management personnel of the Company control 1.31% (30 June 2020: 3.72%, 31 December 2019: 4.17%) of the

voting shares of the Company.

14. EXECUTIVE EMPLOYEE SHARE SCHEMES

Comvita Limited has an Executive Share Scheme called the Comvita Limited Partly Paid Share Scheme (“The Scheme”). The Scheme is

designed to provide key employees with an opportunity to benefit from share price growth. A summary of the key points is disclosed in the

most recent annual financial statements.

Movements in the number of share entitlements outstanding under the scheme are shown below:

in thousands

December 2020

31 December 2019

Number of

Entitlements

Weighted average

exercise price

Number of

Entitlements

Weighted average

exercise price

Entitlements on issue

Entitlements outstanding at beginning of period – July1,228

7.052,0287.59

Entitlements granted-

--

Entitlements converted to ordinary shares -

--

Entitlements forfeited (611)

8.00(700)8.68

Entitlements outstanding at end of period617

6.111,3287.07

On 31 July 2020, Comvita Limited implemented a Performance Share Rights (PSR’s) Scheme to incentivise Executives. The PSR’s are

subject to a vesting period of 3 years. Vesting is subject to continued employment and occurs in 3 tranches (annually). Upon vesting of

the PSR’s, shares will be transferred from treasury stock or new shares will be issued in the capital of the Company on the terms and

conditions described in the Comvita Limited Performance Share Rights Scheme. The shares will be transferred or issued (as applicable) for

no consideration and will be credited as fully paid up. One PSR will convert into one ordinary share upon vesting and will rank equally with all

other ordinary shares on issue. PSRs do not entitle the holder to receive dividends or other distributions, or vote in respect of CVT ordinary

shares. Holders of PSRs cannot transfer or grant security interests over them.

In thousands

December 2020

Number of Entitlements

Entitlements on issue

Entitlements outstanding at beginning of period – July-

Entitlements granted – 25 September 2020122

Entitlements granted - 4 December 202025

Entitlements outstanding at end of period147

15. CAPITAL COMMITMENTS

At 31 December the Group has committed to spending $4,000,000 over the next 3 years.. The capital commitment relates to plantation

costs and other capital projects.

Notes to the Condensed Interim Financial Statements

16. SUPPLEMENTARY NON-GAAP INFORMATION - EBITDA

Earnings before interest, tax, depreciation, and amortisation (EBITDA) is a non-GAAP measure. We monitor this as a key performance

indicator and believe it assists investors in assessing the performance of the core operations of our business.

In thousands of New Zealand dollars

31 December 2020

Unaudited

31 December 2019

Unaudited

Profit before tax4,416(16,137)

Add back: net finance cost1,1402,219

EBIT5,556(13,918)

Add back: depreciation and amortisation5,0395,089

EBITDA10,595(8,829)

Notes to the Condensed Interim Financial Statements

Comvita Condensed Interim Financial Statements 2021 - P18Comvita Condensed Interim Financial Statements 2021 - P19
DIRECTORS

COMVITA Board Of Directors

Brett Donald Hewlett

Lucas (Luke) Nicholas Elias Bunt

Sarah Jane Kennedy

Paul Robert Thomas Reid

Robert Malcolm Major

Dayong Cheng

Guangping Zhu

REGISTERED OFFICE

Comvita Limited

23 Wilson Road South, Paengaroa

Private Bag 1, Te Puke 3153

Bay of Plenty, New Zealand

Phone +64 7 533 1426

Fax +64 7 533 1118

Freephone 0800 504 959

Email investor-relations@comvita.com

www.comvita.com

BANKERS

Westpac Banking

Corporation

Level 8

16 Takutai Square

PO Box 934

Auckland 1142

SOLICITORS

Sharp Tudhope

Level 4

152 Devonport Road

Private Bag TG12020

Tauranga 3110

Directory

AUDITORS

KPMG

Level 2,

247 Cameron Road

Tauranga 3140

SHARE REGISTRY

Link Market Services Limited

PO Box 91976

Auckland 1142

Directory

NORTH AMERICA

Comvita USA Inc.

506 Chapala Street

Santa Barbara,

CA 93101 | USA

Phone +1 855 449 2201

usacustomerservice@comvita.com

CHINA

Comvita Food (China) Limited

2501 - 2502 No. 7018 Sunhope E-Metro

Caitan Road

Futian District

Shenzhen | China

Phone +86 755 8366 1958

comvita@comvita.com.cn

UNITED KINGDOM

Comvita UK Limited

2nd Floor, 47a High Street

Maidenhead, SL61JT

United Kingdom

Phone +44 1628 779 460

info@comvita.co.uk

NEW ZEALAND

Comvita New Zealand Limited

23 Wilson Road South | Paengaroa

Private Bag 1 | Te Puke 3153

Bay of Plenty | New Zealand

Phone +64 7 533 1426

Freephone 0800 504 959

info@comvita.com

HONG KONG

Comvita HK Limited

Room 1320 – 1322 Leighton Centre

77 Leighton Road

Causeway Bay

Hong Kong

Phone +852 2562 2335

cs@comvita.com.hk

SOUTH KOREA

Comvita Korea Co Limited

18F Gwanghwamun Building,

149 Sejong-daero, Jongno-gu, Seoul(03186),

Korea

Phone +82 2 2631 0041

service.korea@comvita.com

AUSTRALIA

Comvita Australia Pty Limited

10 Edmondstone Street

South Brisbane

Queensland 4101 | Australia

Phone +61 7 3845 1400

Freephone 1800 466 392

Customer Service 1300 653 436

info@comvita.com.au

JAPAN

Comvita Japan K.K.

Sangenjaya Horisho Bld 4F

1-12-39 Taishido, Setagaya-Ku

Tokyo 154-0004 | Japan

Phone +81 3 6805 4780

info@comvita-jpn.com

---

INVESTOR PRESENTATION
HALF YEAR RESULT FY21

Focus

Presented by:

David Banfield, CEO

Nigel Greenwood, CFO

25 February 2021

This presentation is given on behalf of Comvita Limited.
Information in this presentation:

•Should be read in conjunction with, and is subject to, Comvita’s Annual Reports, Interim Reports and market releases on NZX;

•Is from unaudited condensed interim financial statementsfor the six months ended 31 December 2020;

•Includes non-GAAP financial measures such as Operating Profit/(Loss) and Operating EBITDA. These measures do not have a standardised meaning prescribed

by GAAP and therefore may not be comparable to similar financial information presented by other entities. They should not be used in substitution for, or

isolation of, Comvita’s audited financial statements. We monitor these non-GAAP measures as key performance indicators, and we believe it assists investors

in assessing the performance of the core operations of our business.

•May contain projections or forward-looking statements about Comvita. Such forward-looking statements are based on current expectations and involve risks

and uncertainties.Comvita’s actual results or performance may differ materially from these statements;

•Includes statements relating to past performance, which should not be regarded as a reliable indicator of future performance;

•Is for general information purposes only, and does not constitute investment advice; and

•Is current at the date of this presentation, unless otherwise stated.

While all reasonable care has been taken in compiling this presentation, Comvita accepts no responsibility for any errors or omissions.

All currency amounts are in NZ dollars unless otherwise stated.

IMPORTANT NOTICE

•Our Focus
•Arotahi

•Our Unique Business Model

•Why Comvita

•Interim Results FY21

•Cashflow, Inventory, and NetDebt

•Market Segment Performance

•Our Three-point Plan

•Q &A

AGENDA

Working in harmony with bees and nature
in New Zealand to heal and protect the

world.

Our Cause

= LONG-TERM
PROFITABLE GROWTH

AROTAHI

OUR FOCUS

LEVERAGING OUR UNIQUEBUSINESS MODEL
C

OM VIT

A

UNIQUE


‘END T

O END



M ODEL

L

and o

w

ne

r

ship

& r

e

f

or

est

at ion

Har

v

est +

Ext r

ac

t ion +

Supply

+

Supply

+

Ext r

ac

t ion +

L

abor

at

or

y

+

Expor

t t

o

dist ribut

or

s

Supply

+

Ext r

ac

t ion +

L

abor

at

or

y

+

Supply

+

Ext r

ac

t ion +

L

abor

at

or

y

+

Expor

t

t

o

dist rib

ut

or

s +

S

elec

t

ed p

eople

on

t he gr

ound in

m ark

e

t

End to end

management

of br

and

+

Consumer

Intimacy

M ODEL

1

M ODEL

2

M ODEL

4

M ODEL

3

M ODEL

5

Comvita M

o

del

S U P P L

Y

S I D E

D E M A N D & C

O N S

U M E R S I D E

Expor

t

t

o o

v

er

seas dist ribut

or

s / r

eseller

s

Sm all

t

eam in selec

t iv

e m ark

e

t s selling

t

o r

esell

er

s

COVID-19
The global Comvita whānau

•The world has fundamentally changed as a result of COVID and so have we

•Our primary focus has been on the health and wellness of our team around the globe

•The team are all safe and well, though some family members have been affected

•The team response has been amazing in all markets, particularly when we were starting our journey of

transformation at the same time as COVID was hitting markets

•We are proud to be part of the solution for consumers around the world

•The longer-term trend of consumers turning to nature and natural products for solutions to their health and

wellness needs has continued

Market performance –two groups:

1: Balanced distribution model

2: Narrow distribution model

Balanced distribution markets: offline / online 67% of segment revenue
•Markets have all performed well

•Balanced distribution has enabled us to fulfill consumer needs

•Good brand affinity and recognition of Comvita quality

•Growing market share

•Differentiated model enables us to pivot at speed to meet consumer needs and expectations

Narrow distribution markets: 33% of segment revenue

•Primarily AU/NZ, HK, UK have all struggled with top line performance

•All four markets have similar characteristics though route to market varies

•A number of own goals with previous distribution focus and lack of digital capability

Supply

•Good inventory levels in-market to meet demand

•Increased lead times and costs to fulfill highlight benefit of demand/brand focused business

COVID-19

•Comvita support goal of highest standards for all NZ honey
•We have one of the most advanced in-house honey laboratories in the world est. 2012

•We are independently audited by a number of independent external authorities such as Medsafeand the

Ministry for Primary Industries

•Achieved AA rating with BRC, highest standard available

•All products tested for and meet Glyphosate “not detectable’ standard

•Chief Science Officer, Dr Jackie Evans, is part of the Leadership Team

•Committed to invest 1% of earnings in science until 2025.

GLOBAL REGULATORY FRAMEWORK AND

STANDARDS

•Reported NPAT $3.5M vs. ($13M) in PCP
•Reported EBITDA $10.6M vs. ($8.8M) in PCP, an improvement of $19.4M

•Reported revenue $98.9M+5.4%

•Double-digit top and bottom-line growth in focus growth markets

•Gross profit +1080 bps +10.8%

•Marketing Investment +$2.2Mor +25%

•$15M business transformation plan on track

•Strong GP% growth

•$5M Underlying cost reductions

•Significant simplification initiatives on track

•Additional $10M transformation phase two launched

•Net debt reduction* $1.6M , inventory reduction* $14M, operating cash inflow$9.4M

•37% reduction in total recordable Injury frequency rate (TRIFR)

•Full year guidance maintained; dividends expected to resume at full year

*vs. June 2020

HEADLINES

For the six months ended
$’00031 December 2020

31 December

2019Variance $Variance %

UnauditedUnaudited

Revenue98,88593,8545,0315.4%

Gross Profit48,50035,81312,68735.4%

Gross Margin49.0%38.2%1080bps28.3%

Operating Expenses45,34446,902(1,558)(3.3%)

EBITDA10,595(8,829)19,424

Underlying EBITDA*12,09063911,4511792%

Net Profit/(Loss) after tax3,455(12,970)16,425

Net Debt13,90393,151(79,248)(85%)

Operating Cashflow9,4298878,542963%

Inventory98,549116,139(17,590)(15%)

*EBITDA and Underlying EBITDA are non-GAAP measures. We monitor these as a key performance indicators and believe they assist investors in

assessing the performance of the core operations of our business.

KEY FINANCIAL RESULTS

$15M TRANSFORMATION UPDATE
Very good progress so far:

•Strong improvement in $ and % GP in H1

•Forecasting full year GP improvement 6-700 bps versus FY20 full year

(excluding impact of harvest)

•Underlying cost reduction of $5.0Mforecast for full year

•Full year investment of $1.5M to deliver transformation

•SKU reduction on track –30%

•Legal Entity reduction initiated and on track

•Exit from SeaDragoncomplete

On track for completion by Jan 2023 latest.

$10M TRANSFORMATION PROGRAMME
PHASETWO

•Additional$10M transformation plan launched

•Commencing in January 2021

•Targeting further 400-450 bps improvement

•Targeting further $1.5-$2M underlying cost reduction

•Invest an additional $1.5M p.a. to deliver the plan over three years

•Targeting completion in June 2024

Cashflow, Inventory, & Net Debt

•Operating cash inflow $9.4m
•Operating cashflow consistent with operating

profit for six months to

31 December 2020 plus working capital

improvements including inventory reduction of

$14m from 30 June 2020

•Investing activities -continued investment in

Mānukaforests

Cash flow movements

31 Dec 2020

Unaudited

31 Dec 2019

unauditedMovement

Operating cash inflow9,4298878,542

Investing activities(5,660)(3,030)(2,630)

Financing activities(5,543)2,243(7,786)

Cash and cash equivalents14,39710,1994,198

CASHFLOW

•Inventory reduced by $18mvs. 31 December 2019
and $14m vs. 30 June 2020

•Reduction in non-Mānuka honey inventory holding

through bulk sales

•Lower apiary inventory due to change in

recognition of costs

•Net debt decrease of $1.6mvs. 30 June 2020

reflecting ongoing focus on working capital

management

Key Balance Sheet Ratiosas at

31 Dec

2020

unaudited

$’000

31 Dec

2019

unaudited

$’000

30 June 2020

audited

$'000

Total assets282,748303,970286,423

Total inventory98,549116,139112,679

Trade receivables26,22328,91317,726

Working capital125,072140,179128,597

Net debt13,90393,15115,520

Total equity214,991160,624211,748

Net debt to equity ratio7%58%14%

Weighted average shares on issue69,79149,55250,786

INVENTORY & NET DEBT

EBITDA: earnings before interest, tax, depreciation and amortisation and EBITDA operating is adjusted for non-operating items. EBITDA, operating and underlying are non-GAAP measures. We monitor these as a key
performance indicators and believe it assists investors in assessing the performance of the core operations of our business.

31 Dec 2020

EBITDA

$’000​

31 Dec 2019

EBITDA

$’000​

Variance

$’000

Per financial statements10,595(8,829)19,424

Add back non-operating items:​

Comvita China-release ofinventory fair value3,567

Impairment of equity accounted investment2,310

Equity accounted investees on wind up and loan write off669

Fair valuemovements-Sea Dragon​154

Fair value movements –biological assets​72

Other(20)

Total adjustments6,752

Operating result10,595(2,077)12,672

One off costs incurred vs. PCP:

Apiary cost recognition1,097

R&D grant income(717)

Inventory write downs1,1651,806

Divestment of Nelson site500

Restructuring& transformation related costs450970

Other increases(560)

Total adjustments1,9952,716

Underlying result12,59063911,951

•Reported improvement of $19.4M versus PCP

•Underlying improvement of $12M versus PCP

•Key elements ;

•Apiary cost recognition

•R&D grants relating to PCP

•Provisions for non Mānuka Inventory

•Restructure and transformation

Investment

UNDERLYING EARNINGS RECONCILIATION

Impact Of Honey Harvest
On Earnings

New business model implemented
Key aims;

•Highest quality lowest cost

•Reduce downside risk to group performance should there be a poor harvest and build long term

shareholder confidence

•In good years Apiary will continue to contribute to group profits (c$2-$3M)

•In poor harvest years (taking average of the last two poor harvests) will provide zero contribution to

group profits

•To reflect a more balanced risk, new accounting treatment applied in 2021 in these interim results

•Removes some seasonality from earnings

•Good progress, plans on track

HONEY SUPPLY RECAP

Early national crop indicators are mixed
•Record warm temperatures through winter followed by intense an La Nina systempresented some challenges

for the honey season.

•Spring and early summer saw variable weather patterns across the country resulting in a slow start

•Settled, warm conditions since Christmas have been more favourable but still variable.

•Three key criteria:

•Yield (Tonnes)

•Quality of yield

•Cost to extract

Comvita crop

We will update the market on the seasons yields and contribution to Group profits in late April/early May

HONEY SUPPLY 2021

Market Segments

•Our business model is uniquewith our global in market subsidiary team
•Closer to customer

•Closer to consumer

•Faster to act

•Primacy of market

•Team capability enhanced

•Strong growth in focused growth markets

•China: Revenue +20% Net Contribution (NC) + 28%

•North America: Revenue +38% , NC growth +222%

•Market performance segmented;

•Balanced distribution model: All markets performing well

•Narrow distribution model: Markets facing challenges. Plan in place to change model

•Balanced distribution model markets evidence operating leverage potential

•Marketing Investment +25%

•Refining and telling our unique story -Why Comvita.

HEADLINES

•Focus to build momentum in focus growth markets
•Profitable growth in other markets

•Biggest $ issue to resolve Australian market -$5.5M vs. PCP

•Reliance on Daigou

•Reliance on tourism

•Poor digital performance

•Limited brand awareness in ‘home markets’

HEADLINES

PerformanceBalanced

distribution markets

Limited distribution marketsOther

Revenue (NZD)

$62.7m$30.6m$5.6m

Net Contribution

$15.9m$8.0m$0.4m

Net Contribution %

25.3%26.3%7.4%

Performance vs. PCPRevenue +26.1%

Net Contribution +64.1%

Revenue -17.8%

Net Contribution +38.9%

Revenue -19.8%

Net Contribution -62.4%

Digital share

48.0%5.7%0%

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations of our business.

Market Segment Performance

NORTH AMERICA
$11.6m

(2019 : $8.4m)

Figures are on a reported NZD currency basis and based on unaudited results to 31 December2020. Other sales of $5.6m (2020: $7.0m) not shown.

REVENUE PERFORMANCE vs. PCP

( 3 1 D e c e m b e r 2 0 2 0 v s . 3 1 D e c e m b e r 2 0 1 9 )

EMEA

$3.4m

(2019 : $3.4m)

REST OF ASIA

$12.6m

(2019 : $8.5m)

GREATER CHINA

AUSTRALIA

& NZ (ANZ)

$18.1m

(2019 :$22.7m)

25

$47.6m

(2019 : $43.8m)

+38%

+9%

-20%

+48%

Flat

Constant Currency conversion using Last Year’s Actual average FX rates
SALES PERFORMANCE -CONSTANT CURRENCY

6 Months Performance

Sales (000’s)

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

GroupNZD100,19693,9286,2686.7%

Greater ChinaCNY219,818199,27020,54810.3%

Rest of AsiaNZD12,7668,4974,26950.2%

ANZNZD17,99222,727(4,735)(20.8%)

North AmericaUSD7,8515,4972,35342.8%

EMEAGBP1,7521,754(2)(0.1%)

NORTH AMERICA
$3.0m

(2019 : $0.9m)

Figures are on a reported NZD currency basis and based on unaudited results to 31 December2020. Other segment net contribution of $0.4m (2020: $1.1m) not shown.

EMEA

$0.1m

(2019 : Loss $0.9m)

REST OF ASIA

$3.7m

(2019 : $1.5m)

GREATER CHINA

AUSTRALIA

& NZ (ANZ)

$5.8m

(2019 :$6.1m)

$11.2m

(2019 : $7.9m)

+222%

+42%

+151%

-5%

NET CONTRIBUTION SEGMENTPERFORMANCE vs. PCP

( 3 1 D e c e m b e r 2 0 2 0 v s . 3 1 D e c e m b e r 2 0 1 9 )

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations of our business.

Focus Growth Markets
China & North America

Focus

Structured long-term Investment to grow both market and market share

Current business model:Balanced distribution model

Photo source: The Red
GREATER CHINA

On a reported currency basis

•Revenue growth 8.6%

•Strong performance in China offset by challenging topline conditions in HK

•Good Net contribution growth as emphasis on profitable growth delivers

in Hong Kong and China

•Net contribution improved by 42.5% to 23.6% of sales

6 Months Performance

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales47,61543,8423,7738.6%

Net Contribution11,2327,8843,34842.5%

Net Contribution %23.6%18.0%561 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations

of our business. Reported figures using actual translation FX rates in each period.

Photo source: The Red
•China is the world’s biggest honey market at 8.3bn RMB

•Revenue growth of 21% in LC

•Marketing investment increased by 33% to build long term brand loyalty and

advocacy

•Net contribution +28% to 21.2% of sales

MAINLAND CHINA

On a reported currency basis

China

6 Months Performance

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales35,48129,6525,82919.7%

Net Contribution7,5255,8991,62627.6%

Net Contribution %21.2%19.9%132 bps

Net contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations of our business. Dec 2019

net contribution has increased by $2,155k versus previous reporting due to a change in the allocation of cost of sales acrosssegments. Reported figures using actual translation FX rates in each period.

Financial Commentary (USD)
•Revenue +42.8 % with strong growth across all channels

•Net contribution +216% to 25.7%

•Marketing investment +30%.

•Digital sales, which comprised 41% of total sales in H1, were up 87% YoY, including Comvita.com

•Significant contribution percentage due to operating leverage and timing of Sales and OPEX, with

majority of marketing investment planned for H2

•Approx. $850K (NZD) of sales relate to new business

N O R T H A M E R I C A

On a constant currency basis

North America

6 Months Performance

USD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales7,8515,4972,35342.8%

Net Contribution2,0146381,376215.7%

Net Contribution %25.7%11.6%1,405 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations of

our business. Constant Currency conversion using Last Year’s actual translation FX rates

N O R T H A M E R I C A
On a reported currency basis

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales11,6178,4143,20338.1%

Net Contribution3,0319412,090222.2%

Net Contribution %26.1%11.2%1,491 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations of

our business. Reported figures using actual translation FX rates in each period

Market Highlights
•Comvita is the fastest growing Mānuka honey brand in the U.S., in both conventional and natural channels, based on sell

out data

•Increasing rates of sale per point of distribution with key retail customers for Mānuka,

with solid orders committed through balance of FY21

•170% increase in retail distribution for Mānuka in FY21

•Continued distribution growth and marketing focus in “building Toronto region”

•Initiated several new targeted marketing initiatives to drive online and retail

sales with a view towards growing share and size of the Mānuka market

•Earned media impressions of 560 Million in 1H, up 24% vs. PCP

•A majority of marketing investment for the FY21 is planned and being deployed

for H2 to continue supporting the brand’s long-term growth

N O R T H A M E R I C A

REST OF ASIA
JAPAN, KOREA, SEA

Focus

Self funding profitable growth

Current business model:Balanced distribution model

•Total revenue growth +48%
•Net contribution +151% to 29.8% (+1222 bps)

•Key strategic focus Mānuka and propolis

•Balanced distribution model (offline/online) key to sustainable success

R E S T O F A S I A

S E C O N D B I G G E S T R E G I O N

On a reported currency basis

Rest of Asia6 Months Performance

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales12,5728,4964,07648.0%

Net Contribution3,7471,4942,253150.8%

Net Contribution %29.8%17.6%1,222 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations

of our business.Reported figures using actual translation FX rates in each period

ANZ Performance
Australia & New Zealand

Focus

Building domestic strength

Current Business model; Narrow distribution model

New Zealand
•NZ revenue improved versus PCP +10.5%

•COVID-19 continued to impact the

New Zealand business but less than Australia

•Continued Investment in brand

•Forecasting decline in H2 due to travel and Daigou

•Strong digital performance from a low base

Australia

•Revenue reduced by $5.5M versus PCP

•Severely impacted by narrow distribution and

Daigou underperformance

•Continued investment in brand

•Major customer destocking

•Revenue impacts fall through

to NC reduction

A U S T R A L I A & N E W Z E A L A N D

On a constant currency basis

ANZ

6 Months Performance

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales17,99222,726(4,734)(20.8%)

Net Contribution5,7596,071(312)(5.1%)

Net Contribution %32.0%26.7%530 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core

operations of our business.Constant Currency conversion using Last Year’s actual translation FX rates

A U S T R A L I A & N E W Z E A L A N D
On a reported currency basis

ANZ

6 Months Performance

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales18,09222,726(4,634)(20.4%)

Net Contribution5,7696,071(302)(5.0%)

Net Contribution %31.9%26.7%519 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core

operations of our business. Reported figures using actual translation FX rates in each period

EMEA Performance
UK, Europe, Middle East and Africa

Focus

Self funding profitable growth

Current Business model; Narrow distribution model

E U R O P E , M I D D L E E A S T & A F R I C A
( E M E A )

On a constant currency basis

•Revenue flat vs. PCP due to COVID and Brexit challenges

•Broadly breakeven business from loss making in PCP

•Retail distribution impacted by COVID (lockdown)

•New distribution delayed due to COVID

•C£100k pull forward of orders from H2 due to stock filling for Brexit

•Proven that market can be breakeven/profitable

EMEA

6 Months Performance

GBP 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales1,7521,754(2)(0.1%)

Net Contribution67(480)547

Net Contribution %3.9%(27.3%)3,120 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations

of our business. Constant Currency conversion using Last Year’s actual translation FX rates

•Revenue flat vs. PCP due to COVID and Brexit challenges
•Broadly breakeven business from loss making in PCP

•Retail distribution impacted by COVID (lockdown)

•New distribution delayed due to COVID

•C£100k pull forward of orders from H2 due to stock filling for Brexit

•Proven that market can be breakeven/ profitable

E U R O P E , M I D D L E E A S T & A F R I C A

( E M E A )

On a reported currency basis

EMEA

6 Months Performance

NZD 000's

This Year

Dec 2020

Last Year

Dec 2019

vs.

Last Year

vs.

Last Year %

Sales3,3943,444(50)(1.5%)

Net Contribution139(926)1,065

Net Contribution %4.1%(26.9%)3,099 bps

Net Contribution is a non-GAAP measure. We monitor this as a key performance indicator and believe it assists investors in assessing the performance of the core operations

of our business. Constant Currency conversion using Last Year’s actual translation FX rates

Three-part plan
Stabilise, Transform, Build Long Term Resilience

Progress Update And Future Focus

P
R

O

U

D

H

I

S

T

O

R

Y

STAGES OF COMVITA DEVELOPMENT

E

X

C

I

T

I

N

G

F

U

T

U

R

E

CRAWL ONE-YEARSTRIDE 2-3 YEARSRUNONGOING

JAN 2020

Key Achievements:

•Return to profitability

•Reset capital structure

•Low debt model

•Organisation restructure

•Refined purpose

•Cascaded 5-year plan

•Focus on consumers

•Focus on growth markets

•Focus on key products

JAN 2021 -JUNE 24

Key Goals:

•Sustainable profitable growth

(all market segments profitable

and growing)

•World class omni channel capability

•$15M +$10M Transformation

complete

•New revenue streams and RTM

launched

•Brand of choice to discerning

consumers

•Market leader at home

JUNE 24

Key Goals:

•Clear route to carbon neutral and

positive

•Clear route to 20% EBITDA margin

•Strong growth in new categories

•Mid-single-digit Mānuka growth

•Experiential stores around the world

•Multiple global partnerships with

world class organisations

•Recognised for H&S standards

•Best employer

P

R

O

U

D

H

I

S

T

O

R

Y

OUR THREE POINT PLAN Progress and Update
Stabilise the organisation

▪Winning inAustralia and New Zealand

▪Focus on fundamentals

▪Relentless simplification

▪Positive cashflow paying down debt

▪Inventory management

▪Underperforming assets

Transformed organisation

▪Consumer focus

▪Flat organisation structure

▪New proven harvest model

▪Agile focused team

▪$15M transformation plan

▪Reconnection with our cause

Build long term resilience and growth

▪Aligned 5-year plan

▪US and China the engine for sustainable top and bottom-line growth

▪Simplified organisation –lowest headcount since 2011

▪Reducing breakeven point per month from $16.2m to $13.5m

▪Reduced debt <1 EBITDA relative to inventory value

•Grow domestic consumption and relevance in ANZ
•Build brand awareness and loyalty

•Share our unique story

•Launch unique experiential store

•Build authority and leadership with industry, educational establishments, and like-

minded organisations

•All existing markets on track to ‘balanced distribution model‘

•Focus on fundamentals

•Business planning

•End to end integrated processes

•Data as an enabler

•Cash / WC

•Invest / divest / maintain philosophy on all assets

•Primacy of market

•Connection to our purpose and values

S T A B I L I S E P E R F O R M A N C E

•Intimate relationship with consumers
•Household penetration

•Frequency of use

•Brand fanatics

•Share our unique Comvita story

•Experiential brand

•Build authority and leadership with industry, educational establishments and like-

minded organisations

•Additional $10M of efficiencies (on top of $15M)

•Highest quality, lowest cost producer of Mānuka

•All existing markets on track to ‘balanced distribution model‘

•Integrated, automated and scalable internal processes

•Data insights at hand driving decisions

•Radical simplification

•Legal entities

•SKU count

•Organisationalstructure

T R A N S F O R M E D P E R F O R M A N C E

•Mid-single-digit 5-year revenue CAGR
•TAM growth and market share growth in key markets

•Zero long-term debt and 20% EBITDA busines model

•Double-digit EPS growth (5-year CAGR)

•Comvita recognisedas a Superbrand

•New categories launched to drive long term earnings growth

•Partnerships with other global leaders to leverage mutual expertise

•Best employer in New Zealand

•Attraction, development and retention of high capability team

•All global employees as shareholders

•Carbon positive FY30

•TSR vs. NZX 50

B U I L D L O N G T E R M R E S I L I E N C E A N D G R O W T H

Total Market $1.8Bn
12% TAM

= NZD$216M

Imported Honey

Market Share

12%

15% TAM

= NZD$270M

Imported Honey

Market Share

15%

20% TAM

= NZD$360M

Imported Honey

Market Share

20%

CHINA –GROWING THE MARKET AND OUR SHARE

TODAY

B U I L D L O N G T E R M R E S I L I E N C E A N D G R O W T H
W h y

C o m v i t a ?

F U L L Y E A R G U I D A N C E M A I N TA I N E D
•Full year EBITDA guidance at a range of $20.0M to $23.0M

•In line with our previous disclosure, and subject to delivering full year guidance, the Board

reconfirms its commitment to resume dividend payments at the end of this financial year.

•Focus strategy starting to deliver results –Strong H1 result
•Double-digit growth in focus markets

•Good performance in focus categories

•Simplified business

•Product range

•Operating businesses

•Roles and responsibilities

•Additional $10M dollar transformation programme launched

•Transformation of Comvita on track

•Reducing Inventory, generating cash, paying down debt

•Putting in place foundations for long term profitable growth at Comvita

S U M M A R Y

QUESTIONS AND ANSWERS

THANK YOU

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.